期刊文献+

群体药物代谢动力学原理及应用进展 被引量:4

Principle of Population Pharmacokinetics and Progress of its Application
下载PDF
导出
摘要 群体药物代谢动力学(PPK)在西方国家已有将近40年的发展和应用历史,越来越广泛地用于临床合理用药和个体化给药中。本文简要介绍了PPK基本原理,求算PPK参数的有关方法,重点阐述了目前较常应用的非线性混合效应模型法,并列举了群体药物代谢动力学在常规治疗药物监测、个体化给药以及上市前新药研究中的应用实例。 Population pharmacokinetics has been developed and applied for tens of years in many western countries, However,it is much less applied in China. This article mainly introduced the fundamental principle of population pharmacokinetics (PPK), some routine methods to estimate the parameters of PPK and their advantages and disadvantages, and emphasized the methods for nonlinear mixed effects modeling ,which is widely used currently. Finally,we gave some examples for use of PPK in the area of therapeutic drug monitoring (TDM), the use of PPK in individualization regime, and in population analysis of the medicine which has just come into the market.
出处 《医学综述》 2008年第9期1394-1397,共4页 Medical Recapitulate
关键词 群体药物代谢动力学 非线性混合效应模型法 固定效应 Population pharmacokinetics Nonlinear mixed effects modeling Static effect
  • 相关文献

参考文献19

  • 1Willams PJ, Ette EI. The role of population pharmaeokineties in drug development in light of the Food and Drug Administration's Guidance for Industry: population pharmacokinetics [J]. Clin Pharmacokinet ,2000,39 ( 6 ) :385-395.
  • 2Ouellet D, Bockbrader HN, Wesche DL,et al. Population phamlacokinetics of gababentin in infants and children [ J ]. Epilepsy Res,2001,47 (3) :229-241.
  • 3BennttJE, Wakefield JC. A comparision of a Bayesian population method with two methods as implemented in commercially available software [ J ]. J Pharmacokinet Biopharm, 1996, 24 ( 4 ) : 403 -432.
  • 4Best NG ,Tan KK, Gilks WR,et al. Estimation of population pharmacokinetics using the Gibbs sampler[J]. J Pharmacokinet Biopharm, 1995,23 (4) :407-435.
  • 5Sheiner LB. Analysis of pharmacokinetic data using parametric models. Hypothesis tests and confidence intervals [ J ]. J Pharmacokinet Biopharm, 1986,14 ( 5 ) :539-555.
  • 6Guidance for industry : Population pharmacokinetics [ M ]. FDA 1999. Washington: Food and Drug Administration, 1999 : 12-14.
  • 7Xuan D, Lu JF, Nicolau DP,et al. Population pharmacokineties of tobramycin in hospitalized patients receiving once-daily dosing regimen [ J ]. Int J Antimicrob Agents,2000,15 ( 3 ) : 185 -191.
  • 8Krishna S, Nagaraja NV, Planche T,et al. Population pharmacokinetics of intramuscular quinine in children with severe malaria [ J ]. Antimicrob Agents Chemother ,2001,45 ( 6 ) : 1803-1809.
  • 9Chan E, Lee HS, Hue SS ,et al. Population pharmaeokineties of carbamazepine in Singapore epileptic Patients [ J ]. Br J Clin Pharmacol,2001,51 ( 6 ) : 567-576.
  • 10Montgomery M J, Beringer PM, Aminimanizani A, et al. Population pharmacokinetics and use of monte carlo simulation to evaluate currenfly recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis[J]. Antimicmb Agents Chemother,2001, 45(12) :3468-3473.

同被引文献77

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部